Cargando…
Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis
BACKGROUND: To assess the association of HSD17B13 rs72613567:TA allelic variant with liver disease, we performed the current review and meta-analysis. METHODS: Seven studies were identified by a search of CNKI,CBM,MEDLINE, PubMed, EMBASE, and CENTRAL databases from inception to November 2021. Odds r...
Autores principales: | Tang, Shan, Zhang, Jing, Mei, Ting-Ting, Zhang, Wen-Yan, Zheng, Su-Jun, Yu, Hai-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686634/ https://www.ncbi.nlm.nih.gov/pubmed/34930143 http://dx.doi.org/10.1186/s12876-021-02067-y |
Ejemplares similares
-
Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population
por: Chen, Haizhen, et al.
Publicado: (2020) -
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019) -
The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD
por: Vilar-Gomez, Eduardo, et al.
Publicado: (2021) -
HSD17B13: A Potential Therapeutic Target for NAFLD
por: Zhang, Hai-bo, et al.
Publicado: (2022) -
Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
por: Di Sessa, Anna, et al.
Publicado: (2020)